Earlier studies investigating [18F]flortaucipir and [18F]FDG PET in AD found considerable overlap between higher levels of tau tracer uptake and lower levels of metabolic activity [11, 33], with moderate correlation coefficients across 30 predefined brain regions. The gene discussed is MAPT; the disease is Alzheimer disease.